Vector VestAdvertisement SPDR Advertisement
Home > Boards > US OTC > Biotechs >

Galectin Therapeutics Inc. (GALT)

Add GALT Price Alert      Hide Sticky   Hide Intro
Moderator: No Moderator XenaLives, 123tom
Search This Board:
Last Post: 1/26/2015 8:53:27 PM - Followers: 36 - Board type: Free - Posts Today: 0

Galectin Therapeutics is a biotechnology company focused on discovery and development. We apply our leadership in galectin science and drug development to create new therapies for fibrotic disease and cancer. Drug candidates based on our unique carbohydrate technology target galectin proteins, which are key mediators of biologic and pathologic function.

Galectin Therapeutics is pursuing therapies for indications in which galectins have a demonstrated role in the pathogenesis of a particular disease. We focus on diseases with serious, life-threatening consequences to patients, and those where current treatment options are limited. Our strategy is to establish clinical development approaches that add value to the Company in the shortest time possible, and to seek partners as the program advances and requires much greater resources.

Galectin Therapeutics leverages extensive scientific and development expertise as well as established relationships with outside sources to achieve cost effective and efficient development. We are pursuing a clear development pathway to clinical enhancement and commercialization for our lead compounds in liver fibrosis and cancer immunotherapy.

Galectin Therapeutics is pursuing therapies for indications in which galectins have a demonstrated role in the pathogenesis of a particular disease. We focus on diseases with serious, life-threatening consequences to patients, and those where current treatment options are limited. Though we do not have any current marketed products, our research and development programs, designed to ultimately help patients and their physicians, are focused on:




Fibrosis is the development of excess fibrous connective tissue in an organ when exposed to a chronic disease. The longer the disease affects the organ, the more fibrous tissue is deposited and this ultimately results in the failure of the organ. Galectin Therapeutics’ drug candidates provide a promising and exciting new approach for the treatment of fibrotic diseases, including liver, lung and kidney fibrosis. Significant unmet need exists for treatment options in fibrosis. For example, there are currently no approved medical treatments available for the millions of patients in the U.S. who have non-alcoholic steatohepatitis with advanced fibrosis – commonly known as fatty liver disease. Learn about fibrosis and our research in this area including galectin effects on liver fibrosis, lung fibrosis and kidney fibrosis.




Cancer harms the body when damaged cells divide uncontrollably to form lumps or masses of tissue called tumors. Research shows the potential for galectin inhibition to play an important role in cancer therapy, particularly tumor immunotherapy – an emerging treatment that enhances the activity of the immune system against cancer cells. There are more than 100 types of cancers, and for many of these cancers, few treatment options exist. Our drug candidates provide a new and complimentary approach to other drugs on the market for the treatment of cancer. Learn more about cancer and immunotherapy.


  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
Current Price
Bid Ask Day's Range
Option Chain for GALT
GALT News: RedChip Announces Presentation Schedule for Its January 28-29 Online Investor Conference 01/21/2015 10:06:25 AM
GALT News: Current Report Filing (8-k) 01/07/2015 08:07:14 AM
GALT News: Current Report Filing (8-k) 01/07/2015 08:02:50 AM
GALT News: Final Phase 1 Trial Results Demonstrate Galectin Therapeutics' GR-MD-02 is Safe With Potential for Therapeutic Effect on Fibr... 01/07/2015 08:00:00 AM
GALT News: Statement of Changes in Beneficial Ownership (4) 12/17/2014 04:37:25 PM
#1534  Sticky Note This is my final post on any public biotech2010 09/24/14 04:59:33 PM
#1777   Little blurb in this paper...described as "promising agent" Darwinian 01/26/15 08:53:27 PM
#1776   I agree. That was just my frustration getting thefamilyman 01/26/15 03:48:24 PM
#1775   "Question for our CEO - When you changed IRAHopeful 01/26/15 02:22:52 PM
#1774   When may shareholders expect to know the outcome/status Darwinian 01/22/15 04:28:33 PM
#1773   future financing info oldsport 01/22/15 03:15:18 PM
#1772   More data about the design of phase 2, Adi2 01/22/15 03:05:39 PM
#1771   Question for our CEO - When you changed thefamilyman 01/21/15 07:08:35 PM
#1770   GALT is going to have a CEO on-line IRAHopeful 01/21/15 11:01:02 AM
#1769   i meant a penny stock... wrong board... oldsport 01/20/15 06:22:30 PM
#1768   There is no doubt in my mind but thefamilyman 01/20/15 12:43:34 PM
#1767   is the company dumping shares or something ? oldsport 01/20/15 10:26:10 AM
#1766   if phase 2 goes as well as phase 1 oldsport 01/12/15 05:43:08 PM
#1765   LJPC will approach if not pass $30 this starbuxsux 01/12/15 05:18:58 PM
#1764   i would go galtw and spread out the oldsport 01/07/15 10:26:14 PM
#1763   Thank you. That was my assumption. I'm assuming Darwinian 01/07/15 08:32:46 PM
#1761   The over the counter pectin products molecules are IRAHopeful 01/07/15 07:55:46 PM
#1759   This batch will be round #3 starbuxsux 01/07/15 02:30:49 PM
#1758   yes but how fast could you turn them oldsport 01/07/15 02:17:27 PM
#1757   If GALT runs to double digits those warrants starbuxsux 01/07/15 02:15:37 PM
#1756   yes i saw them... 2017 quite a bit oldsport 01/07/15 02:04:31 PM
#1755   If you go back a while on this starbuxsux 01/07/15 01:56:53 PM
#1754   yea saw it on their online site... im oldsport 01/07/15 01:43:21 PM
#1753   GALTW Trading only at $1.75 +0.25 +16.67%!! starbuxsux 01/07/15 01:40:22 PM
#1752   how so ? oldsport 01/07/15 01:37:47 PM
#1751   Meanwhile the GALTW warrants are easy pickings! starbuxsux 01/07/15 01:14:16 PM
#1750   Looking over the presentation on their website, on Darwinian 01/07/15 12:53:25 PM
#1749   I'll say! The 10 day average volume thefamilyman 01/07/15 11:22:07 AM
#1748   this really reaffirms therapeutic side of things... great oldsport 01/07/15 11:10:23 AM
#1747   The silly thing is that there isn't any Darwinian 01/07/15 10:48:23 AM
#1746   wow... 8mg dosing result was impressive... oldsport 01/07/15 09:26:29 AM
#1745   Galectin Therapeutics final Phase 1 trial results demonstrate starbuxsux 01/07/15 09:00:10 AM
#1744   I should hope they are aware already. And Darwinian 01/06/15 11:39:04 AM
#1743   Someone should probably forward that study info to thefamilyman 01/06/15 11:11:13 AM
#1742   GALT products were not used in the study IRAHopeful 01/06/15 11:00:39 AM
#1741   not likely... oldsport 01/06/15 01:08:38 AM
#1740   Does this mean that GALT product was used thefamilyman 01/06/15 12:59:17 AM
#1739   Good question. It's been almost two months since thefamilyman 01/06/15 12:45:45 AM
#1738   good find... what s goin w the phase oldsport 01/05/15 08:04:16 PM
#1737   Specifically ...... Conclusions In experimental hyperaldosteronism, the incre Seagrass 01/05/15 07:00:04 PM
#1736   Galectin and HF! Seagrass 01/05/15 06:56:01 PM
#1735   If there is a buyout GALT can offer DirectionalDriller 12/23/14 11:35:16 AM
#1734   im kinda adrenaline junky so i guess warrants oldsport 12/23/14 11:33:11 AM
#1733   I believe the warrants are the best way. DirectionalDriller 12/23/14 11:28:16 AM
#1732   I'm curious what happens to the warrants if Darwinian 12/23/14 11:14:37 AM
#1731   the best way to play this is warrants ? oldsport 12/23/14 10:55:51 AM
#1730   The warrants expire March 28 2017. Darwinian said "I DirectionalDriller 12/23/14 10:53:55 AM
#1729   someone mentioned the whole tax writeoff thing... anyway oldsport 12/23/14 10:46:56 AM
#1728   I'm in a hole with this but I Darwinian 12/22/14 09:31:38 PM
#1727   Agreed. It's a disappointing and very sad state thefamilyman 12/22/14 12:28:16 PM
#1726   all my stops triggered... what a sorry month... oldsport 12/22/14 09:42:54 AM